Amanda Coleman, PA
Physician Assistant · Idaho Falls, IDNPI 1649864414
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $6,056 of the $6,894 with a category attached, or 87.8%. 36 manufacturers reported payments, led by AbbVie at 33.6% of the total. 2025 is the largest year on record at $1,979, more than ten times the $190 reported in 2021. Among physician assistant clinicians in ID with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 327 payments — averaging $21.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Jazz Pharmaceuticals Inc.$463
- Teva Pharmaceuticals USA, Inc.$446
- Biogen$433
- Avadel CNS Pharmaceuticals, LLC$342
- Harmony Biosciences LLC$309
- plus $3K from 30 others
What the payments were for
- Consulting fees$3505%
- Food & beverage$6,05688%
- Education$4887%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 125 | $2,317 |
| Jazz Pharmaceuticals Inc. | 14 | $463 |
| Teva Pharmaceuticals USA, Inc. | 16 | $446 |
| Biogen | 22 | $433 |
| Avadel CNS Pharmaceuticals, LLC | 9 | $342 |
| Harmony Biosciences LLC | 11 | $309 |
| Inspire Medical Systems, Inc. | 14 | $292 |
| EMD Serono, Inc. | 12 | $273 |
| Sanofi | 12 | $242 |
| Neurocrine Biosciences, Inc. | 11 | $214 |
| Lilly USA, LLC | 9 | $163 |
| Amgen | 7 | $147 |
| Genentech USA, Inc. | 7 | $145 |
| TG Therapeutics, Inc. | 7 | $135 |
| Argenx US, Inc. | 5 | $114 |
| Pfizer | 6 | $101 |
| SK Life Science, Inc. | 4 | $90 |
| Lundbeck LLC | 4 | $78 |
| Bristol Myers Squibb | 4 | $69 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $69 |
| Novartis | 3 | $55 |
| Merz Pharmaceuticals, LLC | 2 | $41 |
| Impel Pharmaceuticals Inc. | 2 | $38 |
| AstraZeneca | 2 | $36 |
| Eisai Inc. | 2 | $36 |
| Boston Scientific | 2 | $34 |
| Axsome Therapeutics, Inc. | 2 | $29 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $26 |
| Vanda Pharmaceuticals Inc. | 1 | $25 |
| Livanova USA, Inc. | 1 | $24 |
| UCB, Inc. | 1 | $22 |
| ANI Pharmaceuticals, Inc. | 1 | $20 |
| Grifols USA, LLC | 1 | $18 |
| Acorda Therapeutics, Inc | 1 | $17 |
| Banner Life Sciences, LLC | 1 | $17 |
| Alnylam Pharmaceuticals Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,894 in reported general payments places this provider in the 95th percentile of 1,027 physician assistant providers in Idaho.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Nurtec OdtRimegepant Sulfate | 34 | $65,202 |
| UbrelvyUbrogepant | 32 | $46,595 |
| Emgality PenGalcanezumab-Gnlm | 58 | $43,254 |
| QuliptaAtogepant | 37 | $40,331 |
| Aimovig AutoinjectorErenumab-Aooe | 49 | $37,795 |
| XcopriCenobamate | 20 | $21,098 |
| Ajovy AutoinjectorFremanezumab-Vfrm | 12 | $11,471 |
| Lamotrigine ErLamotrigine | 11 | $8,404 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 160 | $3,509 |
| Modafinil | 12 | $2,947 |
| Zonisamide | 43 | $2,138 |
| Pregabalin | 36 | $1,745 |
| Lacosamide | 12 | $1,719 |
| RizatriptanRizatriptan Benzoate | 65 | $1,366 |
| Duloxetine Hcl | 33 | $1,060 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieUbrelvy, Qulipta | $2,317 | $86,92669 claims |
| PfizerNurtec Odt | $101 | $65,20234 claims |
| SK Life Science, Inc.Xcopri | $90 | $21,09820 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,027 physician assistant providers in Idaho.
Other physician assistant in Idaho Falls
- Tyler PondIdaho Falls$13K
- Jed WillardsonIdaho Falls$12K
- Joshua KillpackIdaho Falls$11K
- Phillip MarloweIdaho Falls$10K
- Tyson ParkerIdaho Falls$10K
- Rebecca NewbyIdaho Falls$9K
- Todd CranorIdaho Falls$9K
- Lindsi GordonIdaho Falls$9K
- Alan AdamsIdaho Falls$7K
- Melissa BatesIdaho Falls$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.